drugset / Trial / NCT06426056
Nab-Paclitaxel Plus Cisplatin With Concurrent Radiotherapy for Patients With Locally Advanced Cervical Cancer: A Multicentre, Single-arm, Phase II Trial.
Phase 2
Not yet recruiting
64 enrolled
Peking University Third Hospital
Affiliated Hospital of Hebei University · collabHebei Medical University Fourth Hospital · collabJilin Provincial Tumor Hospital · collab
NaSingle-groupOpen-labelTreatment
Summary
Based on the Phase I trial completed by the sponsor, the Phase II clinical trial aims to investigate the effectiveness and safety of image guidance volume-modulated arc radiation therapy concurrently with Nab-Paclitaxel plus Cisplatin for patients with locally advanced cervical cancer.
Timeline
- Start
- 2024-06
- Primary completion
- 2025-09
- Completion
- 2028-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | 40 mg/m2 | — |
| Subject | Nab-paclitaxel | Small molecule | 33 mg/m2 | — |